Correction to Figure 1 in the PANORAMA Trial Report on Intravitreal Aflibercept for Severe Nonproliferative Diabetic Retinopathy October 1, 2026 Jama Ophthalmology Share Summary Takeaways Listen Clinical Scorecard Quiz Poll